245
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study

, , , , &
Pages 1859-1868 | Published online: 31 Oct 2017

References

  • KesslerRCBerglundPOlga DemlerMAlEThe epidemiology of major depressive disorder results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
  • FerrariAJCharlsonFJNormanREBurden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010PLoS Med20131011e100154724223526
  • RushAJKraemerHCSackeimHAReport by the ACNP task force on response and remission in major depressive disorderNeuropsychopharmacology20063191841185316794566
  • ThaseMEEffectiveness of antidepressants: comparative remission ratesJ Clin Psychiatry200364Suppl 237
  • SheehanDVHarnett-SheehanKSpannMEThompsonHFPrakashAAssessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scaleInt Clin Psychopharmacol2011262758321102344
  • SacchettiaEFrankeESiracusanocARacagnidGVitaaATurrinaCFunctional impairment in patients with major depression in clinical remission: results from the VIVAL-D-Rem, a nationwide, naturalistic, cross-sectional surveyInt Clin Psychopharmacol201530312914125828864
  • FriedEINesseRMThe impact of individual depressive symptoms on impairment of psychosocial functioningPLoS One201492e9031124587318
  • HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry1960231566314399272
  • CirauloDEvansJQiuWShaderRSalzmanCPharmacotherapy of Depression2nd edCirauloDShaderRINew YorkHuman Press2011
  • KellerMBRemission versus response: the new gold standard of antidepressant careJ Clin Psychiatry200465Suppl 4535915046542
  • CusinCYangHYeungAFavaMHandbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health2010
  • FrankEPrienRFJarrettRBConceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrenceArch Gen Psychiatry19914898518551929776
  • KellerMartin BPast, present, and future directions for defining optimal treatment outcome in depressionJAMA2003289233152316012813121
  • ThaseMEEvaluating antidepressant therapies: remission as the optimal outcomeJ Clin Psychiatry200364Suppl 131825
  • FavaGARuiniCBelaiseCThe concept of recovery in major depressionPsychol Med200737330731717311684
  • FavaGAVisaniDPsychosocial determinants of recovery in depressionDialogues Clin Neurosci200810446147219170403
  • ZimmermanMMcGlincheyJBPosternakMAHow should remission from depression be defined? The depressed patient’s perspectiveAm J Psychiatry200616314815016390903
  • SladeMHaywardMRecovery, psychosis and psychiatry: research is better than rhetoricActa Psychiatr Scand20071162818317650268
  • McKnightPEKashdanTBThe importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment researchClin Psychol Rev2010293140
  • MuñozRAMcBrideMEBrnabicAJMMajor depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms, and quality of lifeJ Affect Disord2005861939815820276
  • CurryJSilvaSRohdePRecovery and recurrence following treatment for adolescent major depressionArch Gen Psychiatry201168326326921041606
  • MeyersBSSireyJABruceMPredictors of early recovery from major depression among persons admitted to community-based clinics: an observational studyArch Gen Psychiatry200259872973512150649
  • LorantVDeliègeDEatonWRobertAPhilippotPAnsseauMSocioeconomic inequalities in depression: a meta-analysisAm J Epidemiol200315729811212522017
  • OtteCIncomplete remission in depression: role of psychiatric and somatic comorbidityDialogues Clin Neurosci200810445346019170402
  • BolandRJKellerMartin BThe course of depressionDavisKLCharneyDCoyleJTNemeroffCNeuropsychopharmacology: The Fifth Generation of ProgressAmerican College of Neuropsychopharmacology200210091015
  • World Medical AssociationWorld Medical Association Declaration of Helsinki – Ethical Principles for Medical Research Involving Human SubjectsJAMA2013310202191219424141714
  • ICH Harmonised Tripartite GuidelineGuideline for good clinical practice E6(R1)ICH Harmon Tripart Guidel199619964i53
  • DueñasHLeeABrnabicAJMFrequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational studyInt J Psychiatry Clin Pract2011152809022121855
  • DueñasHBrnabicAJMLeeATreatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational periodInt J Psychiatry Clin Pract201115424225422121997
  • WHOThe ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic GuidelinesWHO1992
  • American Psychiatric Association (APA)Diagnostic and Statistical Manual of Mental Disorders4th ed text revisionAPA2000
  • GuyWECDEU Assessment Manual for Psychopharmacology (Revised)1976
  • McGahueyCGelenbergALaukesCThe Arizona Sexual Experience Scale (ASEX): reliability and validityJ Sex Marital Ther2000261254010693114
  • RushAJTrivediMHIbrahimHMThe 16-Item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiol Psychiatry200354557358312946886
  • DueñasHLaraCWaltonRJGrangerREDossenbachMRaskinJThe integral inventory for depression a new self rated clinimetric instrument for the emotional and painful dimensions in major depressive disorderInt J Psychiatry Clin Pract ISSN2011153171179
  • BerwickDMMurphyJMGoldmanPAWareJEJBarskyAJWeinsteinMCPerformance of a five-item mental health screening testMed Care19912921691761994148
  • KroenkeKSpitzerRWilliamsJPhysical symptoms in primary care: predictors of psychiatric disorders and functional impairmentArch Fam Med199437747797987511
  • SheehanDHarnett-SheehanKRajBThe measurement of disabilityInt Clin Psychopharmacol199611Suppl 38995
  • FurukawaTAAssessment of mood: guides for cliniciansJ Psychosom Res201068658158920488276
  • BerkMNgFDoddSThe validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical useJ Eval Clin Pract200814697998318462279
  • DueñasHLaraCWaltonRJGrangerREDossenbachMRaskinJThe integral inventory for depression, a new, self-rated clinimetric instrument for the emotional and painful dimensions in major depressive disorderInt J Psychiatry Clin Pract201115317117922121927
  • SheehanKHSheehanDVAssessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability ScaleInt Clin Psychopharmacol2008232708318301121
  • AkerbladA-CBengtssonFEkseliusLvon KnorringLEffects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitionersInt Clin Psychopharmacol20031834735414571155
  • AkerbladA-CBengtssonFvon KnorringLEkseliusLResponse, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome studyInt Clin Psychopharmacol200621211712416421464
  • JuliusRJJNovitskyMAJrDubinWRMedication adherence: a review of the literature and implications for clinical practiceJ Psychiatr Pract V20091513444
  • PampallonaSBolliniPTibaldiGKupelnickBMunizzaCPatient adherence in the treatment of depressionBr J Psychiatry200218010410911823317
  • ViinamäkiHHaatainenKHonkalampiKWhich factors are important predictors of non recovery from major depression: a 2 year prospective observational studyNord J Psychiatry200660541041617050300
  • HongJNovickDMontgomeryWReal-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaAsia-Pacific Psychiatry20168515925808275
  • NovickDMontgomeryWHaroJMFunctioing in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaNeuropsychiatr Dis Treat201512383392
  • ThaseMEEntsuahARRudolphRLRemission rates during treatment with venlaxafine or selective seretonin reuptake inhibitorsBr J Psychiatry200117823424111230034
  • EntsuahARHuangHThaseMEResponse and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placeboJ Clin Psychiatry2001621186987711775046
  • PapakostasGIThaseMEFavaMNelsonJCSheltonRCAre antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agentsBiol Psychiatry200762111217122717588546
  • CiprianiAKoestersMFurukawaTADuloxetine versus other anti-depressive agents for depression AndreaCochrane Database Syst Rev201212CD006533
  • HansenRAGartlehnerGLohrKNGaynesBNCareyTSEfficacy and safety of second-generation antidepressants in the treatment of major depressive disorderAnn Intern Med2005143641542616172440
  • MöllerHJRating depressed patients: observer- vs self-assessmentEur Psychiatry200015316017210881213
  • UherRPerlisRHPlacentinoASelf-report and clinician-rated measures of depression severity: can one replace the other?Depress Anxiety201229121043104922933451
  • TadaMUchidaHSuzukiTAbeTPollockBGMimuraMBaseline difference between patients’ and clinicians’ rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the STAR*D dataJ Clin Psychopharmacol201434329730224743720
  • van GriekenRABeuneEJAJKirkenierACEKoeterMWJvan ZwietenMCBScheneAHPatients’ perspectives on how treatment can impede their recovery from depressionJ Affect Disord201416715315924972363
  • American Psychiatric Association (APA)Practice Guideline for the Treatment of Patients with Major Depressive Disorder3rd edAmerican Psychiatric Association2010
  • AnthonyWARecovery from mental illness: the guiding vision of the mental health service system in the 1990sPsychosoc Rehabil J19931641123
  • BarberMERecovery as the new medical model for psychiatryPsychiatr Serv201263327727922388534
  • RobinsonDGWoernerMGMcMenimanMMendelowitzABilderRMSymptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorderAm J Psychiatry2004161347347914992973
  • HarrisonGHopperKIMCraigTRecovery from psychotic illness: a 15- and 25-year international follow-up studyBr J Psychiatry2001178650651711388966
  • AngstJSexual problems in healthy and depressed personsInt Clin Psychopharmacol199813Suppl 6S1S4
  • BonierbaleMLanconCTignolJThe ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in FranceCurr Med Res Opin200319211412412740155